Preeta Kaur Chugh

Summary

Publications

  1. pmc An assessment of vitamin supplements in the Indian market
    Preeta K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, Bahadur Shah Zafar Marg, New Delhi 110 002, India
    Indian J Pharm Sci 74:469-73. 2012
  2. ncbi Biosimilars: current scientific and regulatory considerations
    Preeta Kaur Chugh
    Department of Pharmacology, Vardhman Mahavir Medical College and Associated Safdarjung Hospital, House No 73, G F, Hemkunt Colony, Greater Kailash Part I, New Delhi 110048, India
    Curr Clin Pharmacol 9:53-63. 2014
  3. doi Predictive value of symptoms for quality of life in first-episode schizophrenia
    Preeta Kaur Chugh
    Lady Hardinge Medical College, Department of Psychiatry of Children, Adolescents and Adults, New Delhi 1, India
    Nord J Psychiatry 67:153-8. 2013
  4. doi Management of women with systemic lupus erythematosus
    Preeta Kaur Chugh
    Department of Pharmacology, Vardhman Mahavir Medical College and Associated Safdarjung Hospital, New Delhi, India
    Maturitas 75:207-14. 2013
  5. ncbi Belimumab: targeted therapy for lupus
    Preeta K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India
    Int J Rheum Dis 16:4-13. 2013
  6. ncbi Recent advances in the pathophysiology and pharmacological treatment of obesity
    P K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India
    J Clin Pharm Ther 37:525-35. 2012
  7. doi Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial
    Preeta Kaur Narula
    Department of Pharmacology, Lady Hardinge Medical College and Associated SSK Hospitals, New Delhi, India
    Schizophr Res 118:218-23. 2010
  8. doi Lupus: novel therapies in clinical development
    Preeta Kaur Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, Bahadur Shah Zafar Marg, New Delhi 110002, India
    Eur J Intern Med 23:212-8. 2012

Collaborators

  • S Sharma
  • Preeta Kaur Narula
  • K E S Unni
  • Neeraj Gupta
  • H S Rehan

Detail Information

Publications8

  1. pmc An assessment of vitamin supplements in the Indian market
    Preeta K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, Bahadur Shah Zafar Marg, New Delhi 110 002, India
    Indian J Pharm Sci 74:469-73. 2012
    ..There is a need for proper guidelines and regulations for the manufacturing, labelling and marketing of dietary supplements in India. Strict enforcement of such provisions is essential to safeguard the health of the population at large...
  2. ncbi Biosimilars: current scientific and regulatory considerations
    Preeta Kaur Chugh
    Department of Pharmacology, Vardhman Mahavir Medical College and Associated Safdarjung Hospital, House No 73, G F, Hemkunt Colony, Greater Kailash Part I, New Delhi 110048, India
    Curr Clin Pharmacol 9:53-63. 2014
    ..Future holds promise for biosimilars to provide affordable, efficacious and safe treatment to a vast majority of patients with significant cost savings to the nation...
  3. doi Predictive value of symptoms for quality of life in first-episode schizophrenia
    Preeta Kaur Chugh
    Lady Hardinge Medical College, Department of Psychiatry of Children, Adolescents and Adults, New Delhi 1, India
    Nord J Psychiatry 67:153-8. 2013
    ..Management of the disease symptomatology impacts the long-term functioning and quality of life (QOL) in psychotic patients...
  4. doi Management of women with systemic lupus erythematosus
    Preeta Kaur Chugh
    Department of Pharmacology, Vardhman Mahavir Medical College and Associated Safdarjung Hospital, New Delhi, India
    Maturitas 75:207-14. 2013
    ..A team of multidisciplinary specialists is required to ensure aggressive and comprehensive management of risk factors, treatment of symptoms and prevention of complications to ensure successful outcomes...
  5. ncbi Belimumab: targeted therapy for lupus
    Preeta K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India
    Int J Rheum Dis 16:4-13. 2013
    ..It could enable development of treatment which could halt long-term progression, minimize target organ damage and thus provide a better quality of life for these patients...
  6. ncbi Recent advances in the pathophysiology and pharmacological treatment of obesity
    P K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India
    J Clin Pharm Ther 37:525-35. 2012
    ..The increasing prevalence of obesity and associated morbidity present unmet medical needs for safe and effective new drug therapies. Our aim is to review the diverse targets and compounds that are in clinical development...
  7. doi Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial
    Preeta Kaur Narula
    Department of Pharmacology, Lady Hardinge Medical College and Associated SSK Hospitals, New Delhi, India
    Schizophr Res 118:218-23. 2010
    ..The purpose of this study was to assess the efficacy of topiramate to prevent olanzapine induced WG in these cases. We also studied various metabolic parameters...
  8. doi Lupus: novel therapies in clinical development
    Preeta Kaur Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, Bahadur Shah Zafar Marg, New Delhi 110002, India
    Eur J Intern Med 23:212-8. 2012
    ..This review discusses various drugs which are in different phases of clinical trials and hold promise for patients suffering from this chronic debilitating disease...